v3.26.1
Acquisitions - Symbiosys Acquisition Narrative (Details) - Symbiosys Acquisition - USD ($)
$ in Millions
6 Months Ended
Jun. 30, 2026
May 28, 2025
Business Combination [Line Items]    
Deferred cash consideration $ 15  
Deferred cash consideration remaining 14  
Holdback consideration for acquisitions 14  
Compensation costs 53  
Intangible assets   $ 19
Existing technology    
Business Combination [Line Items]    
Intangible assets $ 17  
Estimated Useful Life 4 years  
Customer relationships    
Business Combination [Line Items]    
Intangible assets $ 2  
Estimated Useful Life 3 years